Park Capital Management LLC WI Takes Position in Axon Enterprise, Inc $AXON

Key Points

• Park Capital Management LLC acquired a new stake in Axon Enterprise valued at approximately $512,000, purchasing 619 shares during the second quarter.
• Insider trading reveals that President Joshua Isner sold 15,919 shares for over $11.8 million, representing a 6.26% decrease in his ownership.
• Several analysts have raised their price targets for Axon Enterprise, with Bank of America increasing its target from $895.00 to $1,000.00, indicating strong market confidence.

Park Capital Management LLC WI purchased a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 619 shares of the biotechnology company's stock, valued at approximately $512,000.

Other institutional investors also recently bought and sold shares of the company. LaSalle St. Investment Advisors LLC boosted its stake in Axon Enterprise by 2.1% during the first quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company's stock worth $408,000 after buying an additional 16 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in Axon Enterprise by 5.0% during the first quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company's stock worth $203,000 after buying an additional 18 shares during the last quarter. Pinion Investment Advisors LLC boosted its stake in Axon Enterprise by 3.0% during the first quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company's stock worth $341,000 after buying an additional 19 shares during the last quarter. Kentucky Retirement Systems boosted its stake in Axon Enterprise by 0.4% during the first quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company's stock worth $2,605,000 after buying an additional 19 shares during the last quarter. Finally, WCM Investment Management LLC boosted its stake in Axon Enterprise by 0.8% during the first quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company's stock worth $1,306,000 after buying an additional 19 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CAO Jennifer H. Mak sold 77 shares of Axon Enterprise stock in a transaction on Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the transaction, the chief accounting officer owned 15,003 shares in the company, valued at approximately $11,402,280. This trade represents a 0.51% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the completion of the transaction, the president owned 238,379 shares in the company, valued at $177,892,712.54. The trade was a 6.26% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 44,932 shares of company stock valued at $34,408,816. 4.40% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities analysts have recently commented on AXON shares. Bank of America upped their price target on Axon Enterprise from $895.00 to $1,000.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Wolfe Research started coverage on Axon Enterprise in a research note on Monday, July 7th. They issued an "outperform" rating on the stock. Northland Securities set a $800.00 price target on Axon Enterprise in a research note on Tuesday, August 5th. Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the stock an "overweight" rating in a research note on Friday, July 11th. Finally, UBS Group reissued a "neutral" rating and set a $840.00 target price (up previously from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $837.69.

Axon Enterprise Stock Up 1.1%

Shares of AXON traded up $8.06 during mid-day trading on Friday, reaching $774.53. The company's stock had a trading volume of 1,738,952 shares, compared to its average volume of 424,076. Axon Enterprise, Inc has a 12-month low of $387.06 and a 12-month high of $885.91. The company's 50 day moving average is $759.97 and its 200 day moving average is $695.31. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The stock has a market cap of $60.80 billion, a PE ratio of 191.24, a price-to-earnings-growth ratio of 28.43 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts' consensus estimates of $1.54 by $0.58. The company had revenue of $668.54 million during the quarter, compared to analysts' expectations of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm's revenue for the quarter was up 32.6% on a year-over-year basis. During the same period last year, the firm earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Equities analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.